Suicide attempts in high-dose benzodiazepine users

Comprehensive Psychiatry

Volumn 43, Issue 6, 2002, Pages 438-442

  Lekka, Nicoletta P ^a   Paschalis, Christos ^a   Beratis, Stavroula ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BROMAZEPAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLUNITRAZEPAM; LORAZEPAM; PRAZEPAM; TEMAZEPAM; TRIAZOLAM;

ADULT; ARTICLE; BORDERLINE STATE; COMORBIDITY; CONTROLLED STUDY; DRUG ABUSE; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; REGRESSION ANALYSIS; SUICIDE ATTEMPT;

EID: 0036851698     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1053/comp.2002.35912     Document Type: Article

References (29)

1. Hollister LE, Muller-Oerlinghausen B, Rickels, K. Clinical uses of benzodiazepines. J Clin Psychopharm 1993;13(1 Suppl):1S-169S.
2. Williams DD, McBride A. Benzodiazepines: Time for reassessment. Br J Psychiatry 1998;173:361-362.
3. Taylor S, McCracken CFM, Wilson KCM, Copeland JRM. Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. Br J Psychiatry 1998;173:433-438.
4. Uhlenhuth EH, Balter M, Ban A. International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: V: Treatment strategies in panic disorder, 1992-1997. J Clin Psychopharm 1998;18(Suppl):27S-31S.
5. Tondo L, Baldessarini RJ, Hennen J, Minnai GP, Salis P, Scamonatti L, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 1999;60(2 Suppl):63-69.
6. Woods JH, Katz JL, Winger G. Use and abuse of benzodiazepines: Issues relevant to prescribing. JAMA 1988;260:3476-3480.
7. Garvey MJ, Tollefson GD. Prevalence of misuse of prescribed benzodiazepines in patients with primary anxiety disorder or major depression. Am J Psychiatry 1986;143:1601-1603.
8. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997;7:568-574.
9. Pirkola SP, Isometsa ET, Heikkinen ME, Henriksson MM, Marttunen MJ, Lonnqvist JK. Female psychoactive substance-dependent suicide victims differ from male. Results from a nationwide psychological autopsy study. Compr Psychiatry 1999;40:101-107.
10. Perera KMH, Jenner FA. Some characteristics distinguishing high and low dose users of benzodiazepines. Br J Addict 1987;82:1329-1334.
11. British National Formulary. Drugs Acting on the Central Nervous System. No. 18. London, UK: Pharmaceutical Press, 1989.
12. Kaplan HI, Sadock BJ. Synopsis of Psychiatry. Behavioral Sciences/Clinical Psychiatry. Ed. 8. Baltimore, MD; Williams & Wilkins, 1998.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. Washington, DC: APA, 1994.
14. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington, DC: American Psychiatric Press, 1997.
15. First M, Spitzer R, Williams J, Smith Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press, 1997.
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
17. SPSS Statistical Package for Social Sciences, Version 8.0 for Windows (Computer Program). Chicago, IL:. SPSS Inc, 1997.
18. Committee on the Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms. Curr Prob 1988;21:1-2.
19. Schweitzer E, Rickels K. Benzodiazepine dependence and withdrawal: A review of the syndrome and its clinical management. Acta Psychiatr Scand 1998;393(Suppl):95-101.
20. Juergens S, Morse R. Alprazolam dependence in seven patients. Am J Psychiatry 1988;145:625-627.
21. Hirschfeld RM, Russell JM. Assessment and treatment of suicidal patients. N Engl J Med 1997;337:910-915.
22. Lekka NP, Paschalis C, Beratis S. Nicotine, caffeine and alcohol use in high- and low-dose benzodiazepine users. Drug Alcohol Depend 1997;47:207-212.
23. Lekka NP, Paschalis C, Ellul J, Beratis S. Psychiatric disorders and comorbidity in high-dose and low-dose benzodiazepine users. Eur Neuropsychopharm 2000;10(3 Suppl):S334-335.
24. Baldessarini RJ, Jamison KR. Effects of medical interventions on suicidal behavior: Summary and conclusions. J Clin Psychiatry 1999;60(2 Suppl):117-122.
25. Leon AC, Friedman RA, Sweeney JA, Brown RP, Mann JJ. Statistical issues in the identification of risk factors for suicidal behavior: The application of survival analysis. Psychiatry Res 1990:31:99-108.
26. Nordstrõm P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wisted A, Nordin C, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24:1-9.
27. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behaviour in psychiatric patients. Am J Psychiatry 1999;156:181-189.
28. Bergman B, Brismar B. Hormone levels and personality traits in abusive and suicidal male alcoholics. Alcohol Clin Exp Res 1994;18:311-316.
29. Mann JJ, Oquendo M, Underwood MD, Arango V. The neurobiology of suicide risk: A review for the clinician. J Clin Psychiatry 1999;60(2 Suppl):7-11.